![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, December 22, 2020 3:40:52 PM
BRPA will become 1 common share of NeuroRX after merger with BRPA completed. If merger falls through you will get $10 per share from trust and lose the rest.
BRPAW are warrants. Each warrants gives you the right to buy 1 shares of common stock in post-merger company for 11.50. There are additional limitations as to cooling period after merger before you can exercise, and company can force to exercise if stock runs too high for too long. These become worthless if merger falls through.
BRPAR is right to 1/10 of a common share of post merger company. Automatically converted post merger but worthless if falls through.
BRPAU is 1 common stock, 1 rights, and 1/2 a warrant.
IMO BRPAR is where it’s at right now given price point of BRPA and BRPAW, but I wouldn’t hold on to any of them for too long if they really run.
https://www.sec.gov/Archives/edgar/data/1719406/000165495420013700/brpa_8k.htm
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM